Review Article
Effects of Novel Anti-VEGF Agents with Intravitreal Conbercept in Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Table 2
The study quality of the included studies assessed by the JADAD score.
| | Author | Randomized | Allocation concealment | Blindness | Withdraw | JADAD score |
| | Tao Zhu (2016) [10] | Yes | N.A. | No | N.A. | 4 | | Minglu Li (2015) [11] | Yes | N.A. | No | N.A. | 4 | | Haijing Cao (2016) [12] | Yes | N.A. | N.A. | N.A. | 5 | | Bo Xiao (2017) [13] | Yes | N.A. | No | N.A. | 4 | | Ji Han (2015) [14] | Yes | N.A. | No | N.A. | 4 | | Hang Shi (2017) [15] | N.A. | N.A. | No | N.A. | 3 | | Yantao Jin (2017) [16] | N.A. | N.A. | No | N.A. | 3 | | Yong Xiao (2017) [17] | N.A. | N.A. | No | N.A. | 3 | | Yiping Li (2017) [18] | N.A. | N.A. | No | N.A. | 3 | | Xiaoli Li (2017) [19] | Yes | N.A. | No | N.A. | 4 | | Yunjie Jiang (2017) [20] | Yes | N.A. | No | N.A. | 4 | | Pengfei Zhang (2018) [21] | N.A. | N.A. | No | N.A. | 3 | | Fei Wang (2018) [22] | Yes | N.A. | No | N.A. | 4 | | Na Duan (2018) [23] | Yes | N.A. | No | N.A. | 4 | | Yanjuan Jin (2015) [24] | N.A. | N.A. | No | N.A. | 3 | | Linig Wang (2018) [25] | Yes | N.A. | No | N.A. | 4 | | Xueying Ji (2019) [26] | Yes | N.A. | No | N.A. | 4 | | Huili Li (2017) [27] | N.A. | N.A. | No | N.A. | 3 | | Xiaoling Zhao (2018) [28] | Yes | N.A. | No | N.A. | 4 |
|
|